Arcadia Investment Management’s AstraZeneca AZN Stock Holding History

Arcadia Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-111	Closed	-$17.3K	–	262
2024 Q2	$17.3K	Hold	111	–	–	﹤0.01%	247
2024 Q1	$15K	Hold	111	–	–	﹤0.01%	258
2023 Q4	$15K	Hold	111	–	–	﹤0.01%	268
2023 Q3	$15K	Hold	111	–	–	﹤0.01%	270
2023 Q2	$15.9K	Hold	111	–	–	﹤0.01%	283
2023 Q1	$15.4K	Hold	111	–	–	﹤0.01%	296
2022 Q4	$15.1K	Buy	+111	New	+$13.9K	﹤0.01%	292
2021 Q1	–	Sell	-800	Closed	-$80K	–	281
2020 Q4	$80K	Hold	800	–	–	0.02%	157
2020 Q3	$88K	Buy	+800	New	+$89K	0.02%	156

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arcadia Investment Management's AZN Position: Q3 2024 in Review

Arcadia Investment Management sold out of AstraZeneca (AZN) in Q3 2024, closing a stake of 111 shares — an estimated $17.3K sold.

Arcadia Investment Management first reported a position in AZN in Q3 2020 and held it in 9 quarters. The position peaked at $88K in Q3 2020. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

Arcadia Investment Management reported no remaining AstraZeneca position as of Q3 2024 after selling out during the quarter.
Arcadia Investment Management sold 111 AstraZeneca shares in Q3 2024, an estimated $17.3K.
Arcadia Investment Management first reported a position in AstraZeneca in Q3 2020 and held it in 9 quarters.
Arcadia Investment Management's AstraZeneca position peaked at $88K in Q3 2020.
1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on Arcadia Investment Management's 13F filing for Q3 2024, filed 29 Oct 2024.